Recruiting
Continuous Glucose Monitoring in Polycystic Ovarian Syndrome
- Sponsor
- The Cleveland Clinic (Academic or other)
- Enrolment
- 40 planned
- Conditions
- Polycystic Ovarian Syndrome (PCOS)
- Interventions
- Stelo glucose biosensor by Dexcom
- Ages
- adults
- Registry
- NCT07392476
Full record on ClinicalTrials.gov
From the registry
The purpose of this study is to learn more about blood sugar control in polycystic ovarian syndrome. The patient will be asked to wear a continuous glucose monitor (CGM) device that is applied to the arm with a sensor or filament that goes under the skin to measure your sugar levels. The patient will wear this at certain time points throughout the study. There will have a total of 2 blood draws (about 1 tsp. of blood) at screening and the 6-month visit, a measure of the patients body muscle and fat (body composition), and fill out a questionnaire at the end of the first 3 months and 6 months. Study participation in the research will last about 6 months.
Primary outcomes
- Continuous Glucose measure derived glucometrics
- Continuous Glucose measure derived glucometrics and Polycystic ovarian syndrome
- Lifestyle behaviors
History
Study completion expected
Primary completion expected
Last registry update
Registered
Started